Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.6 USD | +11.65% |
|
+8.24% | -26.63% |
May. 14 | Transcript : ScPharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | ScPharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar scPharmaceuticals Inc.
Upcoming events on scPharmaceuticals Inc.
Past events on scPharmaceuticals Inc.
2024-06-11 12:30 pm | Annual General Meeting |
2024-06-05 05:00 pm | Jefferies Global Healthcare Conference |
2024-05-20 11:00 am | H.C. Wainwright BioConnect Investor Conference |
2024-05-14 04:30 pm | Q1 2024 Earnings Call |
2024-05-14 04:01 pm | Q1 2024 Earnings Release |
2024-03-13 04:30 pm | Q4 2023 Earnings Call |
2024-03-13 04:01 pm | Q4 2023 Earnings Release |
2024-03-12 02:20 pm | Leerink Partners Global Biopharma Conference |
2024-03-06 12:50 pm | TD Cowen Health Care Conference |
2023-11-15 | Craig-Hallum Alpha Select Conference |
2023-11-14 07:00 am | Jefferies London Healthcare Conference - Fireside Chat |
2023-11-08 04:30 pm | Q3 2023 Earnings Call |
2023-11-08 04:01 pm | Q3 2023 Earnings Release |
2023-09-13 10:00 am | H.C. Wainwright Global Investment Conference |
2023-08-10 04:30 pm | Q2 2023 Earnings Call |
2023-08-10 04:01 pm | Q2 2023 Earnings Release |
2023-06-22 10:00 am | Maxim Group Virtual Healthcare Conference |
2023-06-07 01:00 pm | Jefferies Global Healthcare Conference |
2023-06-06 12:30 pm | Annual General Meeting |
2023-05-10 04:30 pm | Q1 2023 Earnings Call |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 13,6 13,3 2.43% | 39,3 |
EBITDA Million USD | Released Forecast Spread | -32,9 -34,0 3.33% | -29,9 -32,0 6.57% | 0,00 0,00 - | -35,7 -37,8 5.49% | -55,4 -54,7 -1.23% | -55,3 |
EBIT Million USD | Released Forecast Spread | -32,9 -32,1 -2.65% | -29,9 -32,2 7.16% | -25,8 -28,1 8.14% | -36,2 -35,4 -2.19% | -55,4 -54,4 -1.9% | -54,9 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -33,0 -31,1 -6% | -32,2 -34,4 6.36% | -28,0 -30,4 7.72% | -36,8 -37,7 2.17% | -54,8 -56,5 3% | -57,3 |
Net income Million USD | Released Forecast Spread | -33,0 -31,1 -6% | -32,2 -34,4 6.36% | -28,0 -30,1 6.82% | -36,8 -38,0 3.02% | -54,8 -57,3 4.36% | -58,3 |
EPS USD | Released Forecast Spread | -1,77 -1,66 -6.84% | -1,31 -1,40 6.43% | -1,02 -1,10 7.55% | -1,30 -1,35 3.42% | -1,42 -1,49 4.38% | -1,47 |
Announcement Date | 24/03/20 | 23/03/21 | 22/03/22 | 22/03/23 | 13/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 2,06 1,57 31.28% | 1,64 1,62 1.28% | 3,80 3,42 10.99% | 6,10 5,77 5.63% | 6,10 5,98 2.09% | 8,09 | 10,8 | 14,4 | 17,2 | 21,1 |
EBITDA Million USD | Released Forecast Spread | -13,6 -12,6 -7.56% | -15,2 -12,1 -26.02% | -15,8 -15,0 -5.28% | -14,2 | -12,6 | -11,0 | -9,60 | -5,80 | ||||||
EBIT Million USD | Released Forecast Spread | -7,24 -8,13 10.9% | -9,42 -7,99 -17.92% | -10,00 -9,43 -6.01% | -9,50 -10,3 7.41% | -11,6 -9,79 -17.99% | -13,7 -12,9 -6.86% | -14,8 -13,2 -12.41% | -15,3 -14,1 -8.01% | -15,9 -15,6 -1.69% | -14,7 | -13,4 | -11,0 | -10,2 | -6,30 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,73 -8,65 10.61% | -9,70 -8,60 -12.8% | -10,2 -9,99 -1.68% | -9,25 -11,4 18.57% | -11,2 -11,3 1.14% | -14,2 -13,7 -3.69% | -15,6 -13,8 -13.42% | -13,8 -15,1 8.4% | -14,1 -16,8 16.04% | -15,9 | -14,5 | -12,8 | -11,8 | -7,90 |
Net income Million USD | Released Forecast Spread | -7,73 -8,47 8.68% | -9,70 -8,40 -15.47% | -10,2 -9,93 -2.34% | -9,25 -11,4 19.18% | -11,2 -12,7 11.45% | -14,2 -13,6 -3.78% | -15,6 -14,0 -11.62% | -13,8 -16,1 14.34% | -14,1 -17,4 18.93% | -16,0 | -14,9 | -13,3 | -11,8 | -7,90 |
EPS USD | Released Forecast Spread | -0,28 -0,31 9.68% | -0,35 -0,30 -15.39% | -0,37 -0,38 3.27% | -0,30 -0,39 22.28% | -0,30 -0,36 17.13% | -0,36 -0,37 3.74% | -0,41 -0,37 -12.33% | -0,35 -0,42 16.33% | -0,36 -0,44 17.56% | -0,41 | -0,38 | -0,32 | -0,24 | -0,18 |
Announcement Date | 16/05/22 | 09/08/22 | 09/11/22 | 22/03/23 | 10/05/23 | 10/08/23 | 08/11/23 | 13/03/24 | 14/05/24 | - | - | - | - | - |
2024-07-15 | CAMURUS AB: Q2 2024 Earnings Release |
2024-07-16 | GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-17 06:45 am | JOHNSON & JOHNSON: Q2 2024 Earnings Release |
2024-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-18 01:00 am | NOVARTIS AG: Q2 2024 Earnings Release |
2024-07-18 | TEYI PHARMACEUTICAL GROUP CO.,LTD: Q2 2024 Earnings Release |
2024-07-21 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-21 | ALMIRALL, S.A.: Q2 2024 Earnings Release |
2024-07-22 | TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | INNOVIVA, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for scPharmaceuticals Inc.
2024-07-10 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
2024-07-09 07:35 am | SCINOPHARM TAIWAN, LTD.: June 2024 Sales and Revenue Release |
2024-07-03 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
2024-07-02 05:05 am | ONENESS BIOTECH CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-21 11:28 am | DEVA HOLDING: Q1 2024 Earnings Release |
2024-06-13 05:21 pm | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
2024-06-11 01:30 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-07 06:33 am | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
2024-06-07 05:17 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
2024-06-04 05:45 am | ONENESS BIOTECH CO., LTD.: May 2024 Sales and Revenue Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SCPH Stock
- Calendar scPharmaceuticals Inc.